Review Part 3: Human herpesvirus-6 in multiple non-neurological diseases

Journal of Medical Virology

Volumn 82, Issue 11, 2010, Pages 1903-1910

  Ablashi, Dharam V ^a   Devin, Courtney L ^a   Yoshikawa, Tetsushi ^b   Lautenschlager, Irmeli ^c   Luppi, Mario ^d   Kühl, Uwe ^e   Komaroff, Anthony L ^f  

^a The HHV 6 Foundation   (United States)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

HHV 6; Non neurological diseases

Indexed keywords

DRUG HYPERSENSITIVITY; EXANTHEMA SUBITUM; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN HERPESVIRUS 6; ISOLATION AND PURIFICATION; ORGAN TRANSPLANTATION; PATHOGENICITY; REVIEW; VIROLOGY;

DRUG HYPERSENSITIVITY; EXANTHEMA SUBITUM; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 6, HUMAN; HUMANS; ORGAN TRANSPLANTATION; ROSEOLOVIRUS INFECTIONS;

EID: 79952117913     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21860     Document Type: Article

References (115)

1. Abdel Massih RC, Razonable RR. 2009. Human herpesvirus 6 infections after liver transplantation. World J Gastroenterol 15: 2561-2569.
2. Aihara Y, Ito SI, Kobayashi Y, Yamakawa Y, Aihara M, Yokota S. 2003. Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction. Br J Dermatol 149: 165-169.
3. Aita K, Jin Y, Irie H, Takahashi I, Kobori K, Nakasato Y, Kodama H, Yanagawa Y, Yoshikawa T, Shiga J. 2001. Are there histopathologic characteristics particular to fulminant hepatic failure caused by human herpesvirus-6 infection? A case report and discussion. Hum Pathol 32: 887-889.
4. Akashi K, Eizuru Y, Sumiyoshi Y, Minematsu T, Hara S, Harada M, Kikuchi M, Niho Y, Minamishima Y. 1993. Brief report: Severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult. N Engl J Med 329: 168-171.
5. Asano Y, Yoshikawa T, Suga S, Nakashima T, Yazaki T, Fukuda M, Kojima S, Matsuyama T. 1991. Reactivation of herpesvirus type 6 in children receiving bone marrow transplants for leukemia. N Engl J Med 324: 634-635.
6. Balci DD, Peker E, Duran N, Dogramaci CA. 2009. Sulfasalazine-induced hypersensitivity syndrome in a 15-year-old boy associated with human herpesvirus-6 reactivation. Cutan Ocul Toxicol 28: 45-47.
7. Barozzi P, Luppi M, Marasca R, Trovato R, Ceccherini-Nelli L, Torelli G. 1995. Human herpesvirus-6 genome in acute lymphoblastic leukemia: Evidence against an etiologic relationship. Acta Haematol 94: 169-172.
8. Bigalke B, Klingel K, May AE, Beyer M, Hovelborn T, Kandolf R, Gawaz M. 2005. Serious clinical course of myocarditis with "apical ballooning": First presentation of pathogenicity of HHV6 subtype A in myocarditis. Internist (Berl) 46: 1259-1264.
9. Bigalke B, Klingel K, May AE, Kandolf R, Gawaz MG. 2007. Human herpesvirus 6 subtype A-associated myocarditis with 'apical ballooning'. Can J Cardiol 23: 393-395.
10. Bultmann BD, Klingel K, Nabauer M, Wallwiener D, Kandolf R. 2005. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 193: 363-365.
11. Calligaris L, Stocco G, De Iudicibus S, Marino S, Decorti G, Barbi E, Carrozzi M, Marchetti F, Bartoli F, Ventura A. 2009. Carbamazepine hypersensitivity syndrome triggered by a human herpes virus reactivation in a genetically predisposed patient. Int Arch Allergy Immunol 149: 173-177.
12. Campbell KJ, Perkins ND. 2006. Regulation of NF-kappaB function. Biochem Soc Symp 73: 165-180.
13. Caruso A, Rotola A, Comar M, Favilli F, Galvan M, Tosetti M, Campello C, Caselli E, Alessandri G, Grassi M, Garrafa E, Cassai E, Di Luca D. 2002. HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines. J Med Virol 67: 528-533.
14. Caruso A, Favilli F, Rotola A, Comar M, Horejsh D, Alessandri G, Grassi M, Di Luca D, Fiorentini S. 2003. Human herpesvirus-6 modulates RANTES production in primary human endothelial cell cultures. J Med Virol 70: 451-458.
15. Caruso A, Caselli E, Fiorentini S, Rotola A, Prandini A, Garrafa E, Saba E, Alessandri G, Cassai E, Di Luca D. 2009. U94 of human herpesvirus 6 inhibits in vitro angiogenesis and lymphangiogenesis. Proc Natl Acad Sci USA 106: 20446-20451.
16. Chang YL, Parker ME, Nuovo G, Miller JB. 2009. Human herpesvirus 6-related fulminant myocarditis and hepatitis in an immunocompetent adult with fatal outcome. Hum Pathol 40: 740-745.
17. Chiou CC, Chung WH, Hung SI, Yang LC, Hong HS. 2006. Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection. J Am Acad Dermatol 54: S14-S17.
18. Chiou CC, Yang LC, Hung SI, Chang YC, Kuo TT, Ho HC, Hu S, Hong HS, Chung WH. 2008. Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: A study of 30 cases in Taiwan. J Eur Acad Dermatol Venereol 22: 1044-1049.
19. Criado PR, Criado RF, Vasconcellos C, Pegas JR, Cera PC. 2004. Drug-induced hypersensitivity syndrome due to anticonvulsants in a two-year-old boy. J Dermatol 31: 1009-1013.
20. De Bolle L, Naesens L, De Clercq E. 2005. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 18: 217-245.
21. de Pagter PJ, Schuurman R, Meijer E, van Baarle D, Sanders EA, Boelens JJ. 2008a. Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation. J Clin Virol 43: 361- 366.
22. de Pagter PJ, Schuurman R, Visscher H, de Vos M, Bierings M, van Loon AM, Uiterwaal CS, van Baarle D, Sanders EA, Boelens J. 2008b. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: An important risk factor for clinical outcome. Biol Blood Marrow Transplant 14: 831-839.
23. Del Borgo C, Zaniratti S, Minosse C, Vetica A, Bellini A, Soscia F, Missori P, Pierelli F, Curra A. 2009. A case of acute polyradiculoneuropathy, drug-induced hypersensitivity, and HHV-6 infection. Neurology 72: 935-936.
24. Descamps V, Bouscarat F, Laglenne S, Aslangul E, Veber B, Descamps D, Saraux JL, Grange MJ, Grossin M, Navratil E, Crickx B, Belaich S. 1997. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 137: 605-608.
25. Descamps V, Collot S, Houhou N, Ranger-Rogez S. 2003. Human herpesvirus-6 encephalitis associated with hypersensitivity syndrome. Ann Neurol 53: 280.
26. Doniger J, Muralidhar S, Rosenthal LJ. 1999. Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate. Clin Microbiol Rev 12: 367-382.
27. Drobyski WR, Knox KK, Majewski D, Carrigan DR. 1994. Brief report: Fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 330: 1356-1360.
28. Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, Chosidow O, Guillot I, Paradis V, Joly P, Crickx B, Ranger-Rogez S, Descamps V. 2009. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: A cause of unpredictable multiorgan failure. Arch Dermatol 145: 67-72.
29. Fujino Y, Nakajima M, Inoue H, Kusuhara T, Yamada T. 2002. Human herpesvirus 6 encephalitis associated with hypersensitivity syndrome. Ann Neurol 51: 771-774.
30. Fujita A, Ihira M, Suzuki R, Enomoto Y, Sugiyama H, Sugata K, Suga S, Asano Y, Yagasaki H, Kojima S, Matsumoto K, Kato K, Yoshikawa T. 2008. Elevated serum cytokine levels are associated with human herpesvirus 6 reactivation in hematopoietic stem cell transplantation recipients. J Infect 57: 241-248.
31. Fukae S, Ashizawa N, Morikawa S, Yano K. 2000. A fatal case of fulminant myocarditis with human herpesvirus-6 infection. Intern Med 39: 632-636.
32. Gorniak RJ, Young GS, Wiese DE, Marty FM, Schwartz RB. 2006. MR imaging of human herpesvirus-6-associated encephalitis in 4 patients with anterograde amnesia after allogeneic hematopoietic stem-cell transplantation. AJNR Am J Neuroradiol 27: 887-891.
33. Griffiths PD, Ait-Khaled M, Bearcroft CP, Clark DA, Quaglia A, Davies SE, Burroughs AK, Rolles K, Kidd IM, Knight SN, Noibi SM, Cope AV, Phillips AN, Emery VC. 1999. Human herpesviruses 6 and 7 as potential pathogens after liver transplant: Prospective comparison with the effect of cytomegalovirus. J Med Virol 59: 496-501.
34. Halme L, Arola J, Hockerstedt K, Lautenschlager I. 2008. Human herpesvirus 6 infection of the gastroduodenal mucosa. Clin Infect Dis 46: 434-439.
35. Harma M, Hockerstedt K, Krogerus L, Lautenschlager I. 2006a. Pretransplant human herpesvirus 6 infection of patients with acute liver failure is a risk factor for posttransplant human herpesvirus 6 infection of the liver. Transplantation 81: 367-372.
36. Harma M, Hockerstedt K, Lyytikainen O, Lautenschlager I. 2006b. HHV-6 and HHV-7 antigenemia related to CMV infection after liver transplantation. J Med Virol 78: 800-805.
37. Helantera I, Loginov R, Koskinen P, Lautenschlager I. 2008. Demonstration of HHV-6 antigens in biopsies of kidney transplant recipients with cytomegalovirus infection. Transpl Int 21: 980-984.
38. Hoshino K, Nishi T, Adachi H, Ito H, Fukuda Y, Dohi K, Kurata T. 1995. Human herpesvirus-6 infection in renal allografts: Retrospective immunohistochemical study in Japanese recipients. Transpl Int 8: 169-173.
39. Huang H, Kamijima M, Wang H, Li S, Yoshikawa T, Lai G, Huang Z, Liu H, Chen J, Takeuchi Y, Nakajima T, Li L. 2006. Human herpesvirus 6 reactivation in trichloroethylene-exposed workers suffering from generalized skin disorders accompanied by hepatic dysfunction. J Occup Health 48: 417-423.
40. Humar A, Kumar D, Caliendo AM, Moussa G, Ashi-Sulaiman A, Levy G, Mazzulli T. 2002a. Clinical impact of human herpesvirus 6 infection after liver transplantation. Transplantation 73: 599-604.
41. Humar A, Kumar D, Raboud J, Caliendo AM, Moussa G, Levy G, Mazzulli T. 2002b. Interactions between cytomegalovirus, human herpesvirus-6, and the recurrence of hepatitis C after liver transplantation. Am J Transplant 2: 461-466.
42. Imbert-Marcille BM, Tang XW, Lepelletier D, Besse B, Moreau P, Billaudel S, Milpied N. 2000. Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: A single-center prospective longitudinal study of 92 patients. Clin Infect Dis 31: 881-886.
43. Jacobs F, Knoop C, Brancart F, Gilot P, Melot C, Byl B, Delforge ML, Estenne M, Liesnard C. 2003. Human herpesvirus-6 infection after lung and heart-lung transplantation: A prospective longitudinal study. Transplantation 75: 1996-2001.
44. Kano Y, Inaoka M, Shiohara T. 2004. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol 140: 183-188.
45. Kano Y, Hiraharas K, Sakuma K, Shiohara T. 2006. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol 155: 301-306.
46. Kashanchi F, Araujo J, Doniger J, Muralidhar S, Hoch R, Khleif S, Mendelson E, Thompson J, Azumi N, Brady JN, Luppi M, Torelli G, Rosenthal LJ. 1997. Human herpesvirus 6 (HHV-6) ORF-1 transactivating gene exhibits malignant transforming activity and its protein binds to p53. Oncogene 14: 359-367.
47. Krueger GR, Huetter ML, Rojo J, Romero M, Cruz-Ortiz H. 2001. Human herpesviruses HHV-4 (EBV) and HHV-6 in Hodgkin's and Kikuchi's diseases and their relation to proliferation and apoptosis. Anticancer Res 21: 2155-2161.
48. Krueger GRF, Rojo J, Buja LM, Lassner D, Kuehl U. 2008. Human herpesvirus-6 (HHV-6) is a possible cardiac pathogen: An immunihistological and ultrastructural study. Hosp Gen 71: 187-191.
49. Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP. 2005a. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 111: 887-893.
50. Kühl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP. 2005b. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112: 1965-1970.
51. Lacroix A, Jaccard A, Rouzioux C, Piguet C, Petit B, Bordessoule D, Ranger-Rogez S. 2007. HHV-6 and EBV DNA quantitation in lymph nodes of 86 patients with Hodgkin's lymphoma. J Med Virol 79: 1349-1356.
52. Lautenschlager I, Hockerstedt K, Linnavuori K, Taskinen E. 1998. Human herpesvirus-6 infection after liver transplantation. Clin Infect Dis 26: 702-707.
53. Lautenschlager I, Linnavuori K, Hockerstedt K. 2000. Human herpesvirus-6 antigenemia after liver transplantation. Transplantation 69: 2561-2566.
54. Lautenschlager I, Harma M, Hockerstedt K, Linnavuori K, Loginov R, Taskinen E. 2002. Human herpesvirus-6 infection is associated with adhesion molecule induction and lymphocyte infiltration in liver allografts. J Hepatol 37: 648-654.
55. Lehto JT, Halme M, Tukiainen P, Harjula A, Sipponen J, Lautenschlager I. 2007. Human herpesvirus-6 and -7 after lung and heart-lung transplantation. J Heart Lung Transplant 26: 41-47.
56. Levine PH, Ablashi DV, Saxinger WC, Connelly RR. 1992a. Antibodies to human herpes virus-6 in patients with acute lymphocytic leukemia. Leukemia 6: 1229-1231.
57. Levine PH, Jahan N, Murari P, Manak M, Jaffe ES. 1992b. Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). J Infect Dis 166: 291-295.
58. Ljungman P, Singh N. 2006. Human herpesvirus-6 infection in solid organ and stem cell transplant recipients. J Clin Virol 37: S87-S91.
59. Ljungman P, Wang FZ, Clark DA, Emery VC, Remberger M, Ringden O, Linde A. 2000. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol 111: 774-781.
60. Luppi M, Marasca R, Barozzi P, Artusi T, Torelli G. 1993. Frequent detection of human herpesvirus-6 sequences by polymerase chain reaction in paraffin-embedded lymph nodes from patients with angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Leuk Res 17: 1003-1011.
61. Luppi M, Barozzi P, Garber R, Maiorana A, Bonacorsi G, Artusi T, Trovato R, Marasca R, Torelli G. 1998. Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases. Am J Pathol 153: 815-823.
62. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, Fritz P, Klingel K, Kandolf R, Sechtem U. 2004. Cardiovascular magnetic resonance assessment of human myocarditis: A comparison to histology and molecular pathology. Circulation 109: 1250-1258.
63. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, Klingel K, Kandolf R, Sechtem U. 2006. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114: 1581-1590.
64. Mardivirin L, Valeyrie-Allanore L, Branlant-Redon E, Beneton N, Jidar K, Barbaud A, Crickx B, Ranger-Rogez S, Descamps V. 2010. Amoxicillin-induced flare in patients with DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms): Report of seven cases and demonstration of a direct effect of amoxicillin on Human Herpesvirus 6 replication in vitro. Eur J Dermatol 20: 68-73.
65. Maric I, Bryant R, Abu-Asab M, Cohen JI, Vivero A, Jaffe ES, Raffeld M, Tsokos M, Banks PM, Pittaluga S. 2004. Human herpesvirus-6-associated acute lymphadenitis in immunocompetent adults. Mod Pathol 17: 1427-1433.
66. Moschettini D, De Milito A, Catucci M, Marconi A, Rinina C, Bianchi-Bandinelli ML, Valensin PE. 1998. Detection of human herpesviruses 6 and 7 in heart transplant recipients by a multiplex polymerase chain reaction method. Eur J Clin Microbiol Infect Dis 17: 117-119.
67. Neurohr C, Huppmann P, Leuchte H, Schwaiblmair M, Bittmann I, Jaeger G, Hatz R, Frey L, Uberfuhr P, Reichart B, Behr J. 2005. Human herpesvirus 6 in bronchalveolar lavage fluid after lung transplantation: A risk factor for bronchiolitis obliterans syndrome? Am J Transplant 5: 2982-2991.
68. Ogata M, Kikuchi H, Satou T, Kawano R, Ikewaki J, Kohno K, Kashima K, Ohtsuka E, Kadota J. 2006. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: Incidence and clinical significance. J Infect Dis 193: 68-79.
69. Ogata M, Satou T, Kawano R, Takakura S, Goto K, Ikewaki J, Kohno K, Ikebe T, Ando T, Miyazaki Y, Ohtsuka E, Saburi Y, Saikawa T, Kadota J. 2009. Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients. Bone Marrow Transplant. 45: 129-136.
70. Ohashi M, Sugata K, Ihira M, Asano Y, Egawa H, Takada Y, Uemoto S, Yoshikawa T. 2008. Human herpesvirus 6 infection in adult living related liver transplant recipients. Liver Transpl 14: 100-109.
71. Ojima T, Abe K, Ohyashiki JH, Shirakata M, Yamamoto K. 2005. IL-2-regulated persistent human herpesvirus-6B infection facilitates growth of adult T cell leukemia cells. J Med Dent Sci 52: 135-141.
72. Okuno T, Higashi K, Shiraki K, Yamanishi K, Takahashi M, Kokado Y, Ishibashi M, Takahara S, Sonoda T, Tanaka K, Baba K, Yabuchi H, Kurata T, 1990. Human herpesvirus 6 infection in renal transplantation. Transplantation 49: 519-522.
73. Puri RK, Leland P, Razzaque A. 1991. Antigen(s)-specific tumour-infiltrating lymphocytes from tumour induced by human herpes virus-6 (HHV-6) DNA transfected NIH 3T3 transformants. Clin Exp Immunol 83: 96-101.
74. Razzaque A. 1990. Oncogenic potential of human herpesvirus-6 DNA. Oncogene 5: 1365-1370.
75. Razzaque A, Williams O, Wang J, Rhim JS. 1993. Neoplastic transformation of immortalized human epidermal keratinocytes by two HHV-6 DNA clones. Virology 195: 113-120.
76. Rohayem J, Dinger J, Fischer R, Klingel K, Kandolf R, Rethwilm A. 2001. Fatal myocarditis associated with acute parvovirus B19 and human herpesvirus 6 coinfection. J Clin Microbiol 39: 4585-4587.
77. Rotola A, Di Luca D, Cassai E, Ricotta D, Giulio A, Turano A, Caruso A, Muneretto C. 2000. Human herpesvirus 6 infects and replicates in aortic endothelium. J Clin Microbiol 38: 3135-3136.
78. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, Gallo RC. 1986. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234: 596-601.
79. Salonen MJ, Siimes MA, Salonen EM, Vaheri A, Koskiniemi M. 2002. Antibody status to HHV-6 in children with leukaemia. Leukemia 16: 716-719.
80. Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P. 1999. CD46 is a cellular receptor for human herpesvirus 6. Cell 99: 817-827.
81. Sashihara J, Tanaka-Taya K, Tanaka S, Amo K, Miyagawa H, Hosoi G, Taniguchi T, Fukui T, Kasuga N, Aono T, Sako M, Hara J, Yamanishi K, Okada S. 2002. High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood 100: 2005-2011.
82. Seeley WW, Marty FM, Holmes TM, Upchurch K, Soiffer RJ, Antin JH, Baden LR, Bromfield EB. 2007. Post-transplant acute limbic encephalitis: Clinical features and relationship to HHV6. Neurology 69: 156-165.
83. Seishima M, Yamanaka S, Fujisawa T, Tohyama M, Hashimoto K. 2006. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome. Br J Dermatol 155: 344-349.
84. Sekiguchi A, Kashiwagi T, Ishida-Yamamoto A, Takahashi H, Hashimoto Y, Kimura H, Tohyama M, Hashimoto K, Iizuka H. 2005. Drug-induced hypersensitivity syndrome due to mexiletine associated with human herpes virus 6 and cytomegalovirus reactivation. J Dermatol 32: 278-281.
85. Sekine N, Motokura T, Oki T, Umeda Y, Sasaki N, Hayashi M, Sato H, Fujita T, Kaneko T, Asano Y, Kikuchi K. 2001. Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA 285: 1153-1154.
86. Shiohara T, Kano Y. 2007. A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol 33: 124-133.
87. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. 2007. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 156: 1083-1084.
88. Singh N, Husain S, Carrigan DR, Knox KK, Weck KE, Wagener MM, Gayowski T. 2002. Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients. Clin Transplant 16: 92-96.
89. Steininger C, Rassenti LZ, Vanura K, Eigenberger K, Jager U, Kipps TJ, Mannhalter C, Stilgenbauer S, Popow-Kraupp T. 2009. Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia. Eur J Clin Invest 39: 497-506.
90. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. 1998. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 134: 1108-1112.
91. Takahashi H, Tanaka M, Tanikawa A, Toyohara A, Ogo Y, Morimoto A, Harato R, Kobayashi M, Amagai M. 2006. A case of drug-induced hypersensitivity syndrome showing transient immunosuppression before viral reactivation during treatment for pemphigus foliaceus. Clin Exp Dermatol 31: 33-35.
92. Takatsuka H, Wakae T, Mori A, Okada M, Fujimori Y, Takemoto Y, Okamoto T, Kanamaru A, Kakishita E. 2003. Endothelial damage caused by cytomegalovirus and human herpesvirus-6. Bone Marrow Transplant 31: 475-479.
93. Takemoto M, Shimamoto T, Isegawa Y, Yamanishi K. 2001. The R3 region, one of three major repetitive regions of human herpesvirus 6, is a strong enhancer of immediate-early gene U95. J Virol 75: 10149-10160.
94. Teraki Y, Izaki S. 2009. Salazosulfapyridine-induced hypersensitivity syndrome triggered by methotrexate. Clin Exp Dermatol 34: e287-e288.
95. Tohyama M, Yahata Y, Yasukawa M, Inagi R, Urano Y, Yamanishi K, Hashimoto K. 1998. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 134: 1113-1117.
96. Tohyama M, Hashimoto K, Yasukawa M, Kimura H, Horikawa T, Nakajima K, Urano Y, Matsumoto K, Iijima M, Shear NH. 2007. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol 157: 934-940.
97. Tong CY, Bakran A, Peiris JS, Muir P, Herrington CS. 2002. The association of viral infection and chronic allograft nephropathy with graft dysfunction after renal transplantation. Transplantation 74: 576-578.
98. Torelli G, Marasca R, Luppi M, Selleri L, Ferrari S, Narni F, Mariano MT, Federico M, Ceccherini-Nelli L, Bendinelli M, Montagnani G, Montorsi M, Artusi T. 1991. Human herpesvirus-6 in human lymphomas: Identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction. Blood 77: 2251-2258.
99. Toyabe S, Harada W, Suzuki H, Hirokawa T, Uchiyama M. 2002. Large vessel arteritis associated with human herpesvirus 6 infections. Clin Rheumatol 21: 528-532.
100. Tschope C, Bock CT, Kasner M, Noutsias M, Westermann D, Schwimmbeck PL, Pauschinger M, Poller WC, Kuhl U, Kandolf R, Schultheiss HP. 2005. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111: 879-886.
101. Vallbracht KB, Schwimmbeck PL, Kuhl U, Seeberg B, Schultheiss HP. 2004. Endothelium-dependent flow-mediated vasodilation of systemic arteries is impaired in patients with myocardial virus persistence. Circulation 110: 2938-2945.
102. Vallbracht KB, Schwimmbeck PL, Kuhl U, Rauch U, Seeberg B, Schultheiss HP. 2005. Differential aspects of endothelial function of the coronary microcirculation considering myocardial virus persistence, endothelial activation, and myocardial leukocyte infiltrates. Circulation 111: 1784-1791.
103. Wang LR, Dong LJ, Zhang MJ, Lu DP. 2008. Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 42: 673-677.
104. Wu CA, Shanley JD. 1998. Chronic infection of human umbilical vein endothelial cells by human herpesvirus-6. J Gen Virol 79: 1247-1256.
105. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, Kurata T. 1988. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1: 1065-1067.
106. Yoshikawa T, Suga S, Asano Y, Nakashima T, Yazaki T, Sobue R, Hirano M, Fukuda M, Kojima S, Matsuyama T. 1991. Human herpesvirus-6 infection in bone marrow transplantation. Blood 78: 1381-1384.
107. Yoshikawa T, Ihira M, Suzuki K, Suga S, Kito H, Iwasaki T, Kurata T, Tanaka T, Saito Y, Asano Y. 2001. Fatal acute myocarditis in an infant with human herpesvirus 6 infection. J Clin Pathol 54: 792-795.
108. Yoshikawa T, Asano Y, Akimoto S, Ozaki T, Iwasaki T, Kurata T, Goshima F, Nishiyama Y. 2002a. Latent infection of human herpesvirus 6 in astrocytoma cell line and alteration of cytokine synthesis. J Med Virol 66: 497-505.
109. Yoshikawa T, Asano Y, Ihira M, Suzuki K, Ohashi M, Suga S, Kudo K, Horibe K, Kojima S, Kato K, Matsuyama T, Nishiyama Y. 2002b. Human herpesvirus 6 viremia in bone marrow transplant recipients: Clinical features and risk factors. J Infect Dis 185: 847-853.
110. Yoshikawa T, Goshima F, Akimoto S, Ozaki T, Iwasaki T, Kurata T, Asano Y, Nishiyama Y. 2003. Human herpesvirus 6 infection of human epidermal cell line: Pathogenesis of skin manifestations. J Med Virol 71: 62-68.
111. Yoshikawa T, Fujita A, Yagami A, Suzuki K, Matsunaga K, Ihira M, Asano Y. 2006. Human herpesvirus 6 reactivation and inflammatory cytokine production in patients with drug-induced hypersensitivity syndrome. J Clin Virol 37: S92-S96.
112. Zeller A, Schaub N, Steffen I, Battegay E, Hirsch HH, Bircher AJ. 2003. Drug hypersensitivity syndrome to carbamazepine and human herpes virus 6 infection: Case report and literature review. Infection 31: 254-256.
113. Zerr DM, Gupta D, Huang ML, Carter R, Corey L. 2002. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis 34: 309-317.
114. Zerr DM, Corey L, Kim HW, Huang ML, Nguy L, Boeckh M. 2005. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 40: 932-940.
115. Zhou Y, Attygalle AD, Chuang SS, Diss T, Ye H, Liu H, Hamoudi RA, Munson P, Bacon CM, Dogan A, Du MQ. 2007. Angioimmunoblastic T-cell lymphoma: Histological progression associates with EBV and HHV6B viral load. Br J Haematol 138: 44-53.